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1 
Abstract 
 
Candida albicans is a commensal fungus, normally living with its human host, however, it has 
the ability to cause invasive infection. Candida albicans is the fourth most frequent nosocomial 
infection affecting a vulnerable immunocompromised population. Candida albicans exhibits 
different morphologies including yeast, pseudohyphae, and hyphae. The varying morphological 
potential of this organism is a virulence trait. Because of this, research has focused on what 
drives activation of hyphal formation as well as what impedes it. During a filamentation assay, a 
novel observation pertaining to a subgroup of proteins being downregulated early after 
germination, was made. In this study, we constructed an over-expression strain of one of these 
proteins and have used known hypha inducing media to determine if it will have an impact on 
filamentation. With the conditions tested thus far, no significant impacts on morphology have 
been observed. 
 
 
 
 
 
 
 
 
 
2 
Candida albicans is a commensal fungus, normally colonizing the gastrointestinal tract and other 1 
mucosal membranes of its human host. Yet, Candida has virulence potential associated with different 2 
environmental cues affecting signal transduction pathways, making Candida an opportunistic 3 
pathogen as well. Changes in host immunity and complex environmental factors play a large role in 4 
C. albicans transformation from commensal to pathogen. Candida is able to change its phenotypic 5 
state between a single celled yeast to filamentous, hyphal or pseudohyphal, morphologies under 6 
varying circumstances. There are superficial types of Candida infections. Such infections are 7 
prevalent in AIDS patients whom frequently suffer from oropharyngeal infections known as oral 8 
thrush (1–3). Or, it is also known that 75% of women will suffer some form of Candida related 9 
vulvogenital infection at least once in their lifetime, impacting their quality of life (4). Candida 10 
albicans is a top cause of nosocomial infections worldwide (5). In fact, there are about 400,000 11 
bloodstream infections worldwide with a 46-75% mortality rate and 10,000 deaths in the United 12 
States alone, all attributed to a more severe form of Candida bloodstream infection (Reviewed in (6)). 13 
The high mortality rate of this organism makes understanding the associated virulence mechanisms 14 
paramount. 15 
Aside from the high mortality rate, the associated prevalence of Candida infections is important. A 16 
reason for rise in fungal infections can be associated with the growing immunocompromised 17 
populations in a hospital setting, a side effect of the medical advancements granting an increased 18 
volume of patients with hospital stays. Those advancements include organ transplantation, stem cell 19 
transplantation, cancer therapies such as chemotherapy, premature infant deliveries and care, and 20 
implanted medical devices (7). These medical treatments compromise the immunity of patients by 21 
some degree enabling Candida bloodstream infections. Treatment difficulties have arisen as drug 22 
resistance has occurred in virulent strains of candida (8). Treatment difficulties are also exacerbated 23 
3 
by the lack of efficacy in detecting techniques from cultured based diagnostic tests typically used in 24 
detecting fungal infections; it is reported that about 50% of invasive candidiasis cases were missed 25 
by this way of detection (9).  26 
C. albicans has developed strategies in order to survive in different niches of a human host and cause 27 
disease. A highlight here would be the ability of this organism to undergo morphological switching 28 
under varying circumstances (10). Although the importance of morphological switching as a 29 
virulence trait was accepted, there wasn’t a manner of testing whether or not this theory was ‘true’ in 30 
experimental studies until a group constructed a strain that could be regulated between yeast and 31 
filamentous growth form (11). This study was the first time ever where the theory of morphological 32 
switching being necessary for virulence, was proven evident. Morphology becomes important during 33 
biofilm formation, another virulence trait of C. albicans. Biofilms are formed when yeast cells adhere 34 
to a surface, commonly medical implanted devices like heart valves or pacemakers, followed by 35 
hyphal morphogenesis, and eventually the film forms in a population of filamentous and yeast cells 36 
which produce polysaccharides, proteins and nucleic acids (12–14). When biofilms form, they have 37 
the potential of impairing the function of the devices they form on, having the correct surface to 38 
adhere to, as well as maintaining the ability to sustain infection.  (15).  39 
Environmental factors responsible for activation of Candida albicans hyphal growth include: 40 
presence of serum, neutral pH, 5% CO2, and low nitrogen (10, 14, 16, 17). These environmental cues 41 
activate important pathways such as the mitogen activated protein kinase (MAPK), cyclic adenosine 42 
monophosphate (cAMP), calcineurin, and HOG pathways (10, 18).  However, activation of hyphal 43 
growth must be accompanied by downregulation of filament repressors, such as Nrg1 (14, 19). 44 
Previous work in the lab identified a group of proteins that were seen to be degraded early during 45 
filamentation when induced in 37°C, a known activation factor of hyphal formation. This finding 46 
4 
presented the question if the presence of these proteins was necessary for morphogenesis from yeast 47 
form to filamentous growth, as well as what their true function is. The focus of this study is one of 48 
these proteins. However, this protein remains uncharacterized and is called C1_05590_C. The 49 
primary way of analyzing this protein was by increasing its expression levels followed by testing 50 
over-expression strains under the influence of known filamentation activating cues. This allowed for 51 
the determination of whether or not this protein influences the transition from yeast to filamentous 52 
growth. Furthermore, the importance of deciphering events of morphological switching involves the 53 
better understanding of this phenomenon to drive clinical applications directed in reducing the high 54 
mortality rates associated with Candida infections. 55 
 56 
RESULTS AND DISCUSSION 57 
 58 
Wild-type strain SC5314 was used as a control and was grown along sa-C1_05590_C mutants 59 
from the same cell line. There were no significant differences between the two mutant strains and 60 
the wild-type strain when grown in different liquid media. When grown in yeast conditions (28 61 
°C) in liquid YPD, all cells remained in yeast form. When grown in filamentous inducing 62 
conditions corresponding to YPD, GLcNAc, YNB, RPMI, and Spider media, filamentation was 63 
clearly observed amongst all streaked colonies examined. This is reflective of the growth 64 
conditions of the mutants not being affecting differently in any significant pathways involved in 65 
the morphological switching from yeast to filamentous growth form than the wild type strain.  66 
 67 
When strains were grown on solid media under filamentous growth conditions, again, filamentous 68 
growth was observed in all strains. For example, a distinct crenulation on spider media is a typical 69 
5 
macroscopic outcome of SC5314 and this was maintained in the mutant strains macroscopic 70 
analysis. Invasion into the media was also apparent amongst all strains examined as washing of 71 
the cells demonstrated this, indicating again, no impact on filamentous growth form observed in 72 
the mutant strains tested. Lee’s medium contains a variety of amino acids necessary for induction 73 
of filamentous growth from yeast form growth. Similarly, Spider medium is known to induce 74 
filamentous growth based on carbon availability. Lastly, GlcNAc is known to stimulate activating 75 
pathways of hyphae inducing outcomes, such as activating the cAMP signaling pathway.  76 
 77 
METHODS AND MATERIALS 78 
 79 
Entailed in this study was the construction of a Candida albicans vector in order to insert, clone, 80 
and express proteins of interest to analyze their effect under conditions where filamentous growth 81 
is known to be activated. These constructs were made up of CIpSAT-SA, the CIp component being 82 
a modified version of the CIp10 vector, created specifically for Candida integration. The SAT 83 
component was introduced to CIp10, encoding a nourseothricin resistance and replacing the URA 84 
component of CIp10. Finally, the SA component of CIpSAT-SA is the shorter of the two Actin 85 
promoters, which are constitutively on, ensuring the maintenance of elevated levels of 86 
C1_05590_C in mutant strains.  87 
 88 
However, the protein of interest was first designed into a pMiniT which does not integrate well 89 
into Candida cells. Xho1 and Mlu1 enzymes allowed for a sub-cloning of C1_05590_C from a 90 
pMiniT vector into a CIpSAT-SA construct. Once the final transformation was done, the remainder 91 
6 
of the experiment involved culture assays as the primary way of attempting to characterize the role 92 
and function of this novel protein.  93 
 94 
Strains and Growth Conditions 95 
 96 
C. albicans strain SC5314 and mutant strains sa-C1_05590_C were grown on yeast-peptone-97 
dextrose (YPD) agar in 28 °C. The mutant strain was engineered as follows:  5’-Xho1-AUG-His6-98 
C1_05590_C-Myc-TAA-Mlu1-3’ in a pMiniT plasmid. The candida plasmid CIp10 was 99 
reengineered to replace the URA component with a SAT component encoding nourseothricin 100 
resistance for selectivity, as well as incorporating the short act promoter (SA) allowing for 101 
constitutive production of the protein of interest. The name of this new construct is CIpSAT-sa, 102 
maintaining a Xho-1 and Mlu-1 cutsite. The enzymes Xho-1 and Mlu-1 were used to cut out the 103 
designed protein from pMiniT and to linearize CIpSAT-sa. The insert and linearized CIpSAT-sa 104 
were ligated, followed by a Stu-1 digestion to prepare the DNA for an electroporation 105 
transformation into SC5314 cells (20, 21). To ensure the insert integrated into CIpSAT-sa, a 106 
double digestion using Xho-1 and Mlu-1 was done and the DNA lengths of the insert-C1_05590_C 107 
and CIpSAT-sa empty plasmid were compared using gel electrophoresis. After transformation by 108 
electroporation was performed, the plated colonies were picked and patched onto another plate. 109 
This allowed for colonyPCR followed by gel electrophoresis to confirm that the correct product 110 
was growing on the patched plate. Once gel electrophoresis on the double digested DNA and 111 
colonyPCR confirmed the correct transformant was present, a YPD plate was streaked with two 112 
transformants and a WT strain.  113 
 114 
7 
Filamentation Assay 115 
 116 
Two approaches were taken for filamentation assays. One approach was by done by streaking YPD 117 
grown strains onto plates of YPD, YPD+Serum, Spider, and SLAD. All but SLAD were placed in 118 
37 °C to induce filamentation. SLAD was placed in 28 °C. A second approach involved liquid 119 
media. A 1mL aliquot was taken, washed twice with water, and resuspended in water to dilute 120 
(1:20) into fresh media including YPD, Spider, Lee’s, GLcNAc, RPMI, and YNB with shaking at 121 
37 °C for three hours. Following, microscopy was used to visualize the cells for phenotypic 122 
comparison.  123 
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September 6, 2019 
 
David Martin, PhD 
230 Mary Idema Pew Library  
1 Campus Drive  
Allendale, Michigan 49401 
  
Dear Dr. David Martin, 
 
I will soon have a Bachelor of Science in Biochemistry from Grand Valley State 
University and I am currently a Ronald E. McNair Scholar at this institution. My regard for the 
sciences has led me to investigate a component of the organism Candida albicans in the 
Thomas-Cleary Lab, an established laboratory in the biomedical sciences department. Under 
their direction I have used a microbiological approach in uncovering some research questions 
regarding an uncharacterized protein in the organism.  
In my research I used a microbiological approach to examine the impact of the 
uncharacterized protein, C1_05590_C, on filamentation. Morphogenesis is an important 
virulence trait of C.albicans. This fungal microorganism lives as a commensal in most of the 
human population, however, is a known opportunistic pathogen. As a pathogen, Candida is a top 
nosocomial infection, impacting already vulnerable populations. In my recent unpublished 
article, Analyzing the Role of a Protein Downregulated After Induction of Filamentous Growth in 
Candida Albicans, I explain how I conducted this research. This paper entails two focuses: One 
questioning what this proteins impact is during morphological switching in Candida, and two, 
my attempt to uncover what this proteins function in the organism is. To do this, I overexpressed 
the protein by placing it in a vector with a constitutive promoter, allowing for constitutive 
production of it. This was followed by testing the constitutive mutant under conditions known to 
induce filamentation.  
Infection and Immunity is a journal within the American Society of Microbiology and is 
fitting for my article because Candida is known to cause a deep-seated infection. My article 
focuses on a novel protein possibly associated with an important virulence trait of Candida 
infections. The impact of this protein remains enigmatic as it has not been observed to evade 
morphological switching with the media it has been analyzed with. Its function also remains a 
mystery as the mutant has not been observed to function differently than the wild-type strain. 
The research I have conducted will bring attention to this uncharacterized protein, for others to 
continue understanding the underlying mechanisms intrinsic to the virulence trait of phenotypic 
switching. I have contributed to a starting point, where someone else who is intrigued, can carry 
on. The only other known information about this novel gene is given by computational 
predictions. 
 
Thank you, 
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Jazmine Vasquez 
McNair Scholar 
Biochemistry Student 
Grand Valley State University  
616-589-7842 
vasqueja@mail.gvsu.edu 
    
 
Target publication 
 
American Society for Microbiology - Infection and Immunity 
 
